The clinical meaning of pre- and post-ablation thyroglobulin levels at first radioiodine therapy in patients with papillary thyroid cancer
Background/Aims This study was conducted to identify prognostic factors in patients with papillary thyroid cancer (PTC) at the time of first radioactive iodine (RAI) therapy, and to evaluate the clinical value of the thyroglobulin (Tg) increase after RAI. Methods Serum Tg was sampled prior to (pre-T...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
The Korean Association of Internal Medicine
2020-09-01
|
Series: | The Korean Journal of Internal Medicine |
Subjects: | |
Online Access: | http://www.kjim.org/upload/pdf/kjim-2018-173.pdf |
id |
doaj-5768292293164cfc9eadd250b1fd1316 |
---|---|
record_format |
Article |
spelling |
doaj-5768292293164cfc9eadd250b1fd13162021-08-10T06:00:15ZengThe Korean Association of Internal MedicineThe Korean Journal of Internal Medicine1226-33032005-66482020-09-013551164117210.3904/kjim.2018.173170219The clinical meaning of pre- and post-ablation thyroglobulin levels at first radioiodine therapy in patients with papillary thyroid cancerHee Kyung Kim0Jee Hee Yoon1Jin Seong Cho2Seong Young Kwon3Su Woong Yoo4Ho-Cheol Kang5 Departments of Internal Medicine, Chonnam National University Medical School, Gwangju, Korea Departments of Internal Medicine, Chonnam National University Medical School, Gwangju, Korea Departments of Surgery, Chonnam National University Medical School, Gwangju, Korea Departments of Nuclear Medicine, Chonnam National University Medical School, Gwangju, Korea Departments of Nuclear Medicine, Chonnam National University Medical School, Gwangju, Korea Departments of Internal Medicine, Chonnam National University Medical School, Gwangju, KoreaBackground/Aims This study was conducted to identify prognostic factors in patients with papillary thyroid cancer (PTC) at the time of first radioactive iodine (RAI) therapy, and to evaluate the clinical value of the thyroglobulin (Tg) increase after RAI. Methods Serum Tg was sampled prior to (pre-Tg) and 7 days after RAI (post-Tg) in 680 patients with PTC. Patients were classified into excellent response (ER), biochemical incomplete response (BCIR), structural incomplete response (SIR), and indeterminate response (IR) groups using dynamic risk stratification at 6 to 18 months after RAI therapy. Results After RAI therapy, 514 patients (75.6%) had an ER, 34 (5.0%) had a BCIR, 13 (2.0%) had an SIR, and 119 (17.5%) had an IR. Pre-Tg level was significantly different among the groups, with the highest level being in the SIR group, followed by the BCIR, IR, and ER groups. However, post-Tg levels were not different among the groups. Post-Tg level increased significantly after RAI therapy compared to the pre-Tg level (mean 13.8 ± 32.2 ng/mL vs. 2.5 ± 8.9 ng/mL). In 422 patients whose pre-Tg level was < 1 ng/mL, 205 had post-Tg levels < 1 ng/mL, while 167 had post-Tg levels of 1 to 10 ng/mL, and 50 had levels > 10 ng/mL. No difference was observed in the response to therapy. Differences in RAI dose and uptake pattern were observed among the three groups. Conclusions Pre-Tg was useful as a prognostic factor in patients with PTC. In patients with low pre-Tg, increased post-Tg may reflect remnant tissue and does not help predict the prognosis.http://www.kjim.org/upload/pdf/kjim-2018-173.pdfthyroid cancer, papillaryradioactive iodine therapythyroglobulinprognosistherapeutic response |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Hee Kyung Kim Jee Hee Yoon Jin Seong Cho Seong Young Kwon Su Woong Yoo Ho-Cheol Kang |
spellingShingle |
Hee Kyung Kim Jee Hee Yoon Jin Seong Cho Seong Young Kwon Su Woong Yoo Ho-Cheol Kang The clinical meaning of pre- and post-ablation thyroglobulin levels at first radioiodine therapy in patients with papillary thyroid cancer The Korean Journal of Internal Medicine thyroid cancer, papillary radioactive iodine therapy thyroglobulin prognosis therapeutic response |
author_facet |
Hee Kyung Kim Jee Hee Yoon Jin Seong Cho Seong Young Kwon Su Woong Yoo Ho-Cheol Kang |
author_sort |
Hee Kyung Kim |
title |
The clinical meaning of pre- and post-ablation thyroglobulin levels at first radioiodine therapy in patients with papillary thyroid cancer |
title_short |
The clinical meaning of pre- and post-ablation thyroglobulin levels at first radioiodine therapy in patients with papillary thyroid cancer |
title_full |
The clinical meaning of pre- and post-ablation thyroglobulin levels at first radioiodine therapy in patients with papillary thyroid cancer |
title_fullStr |
The clinical meaning of pre- and post-ablation thyroglobulin levels at first radioiodine therapy in patients with papillary thyroid cancer |
title_full_unstemmed |
The clinical meaning of pre- and post-ablation thyroglobulin levels at first radioiodine therapy in patients with papillary thyroid cancer |
title_sort |
clinical meaning of pre- and post-ablation thyroglobulin levels at first radioiodine therapy in patients with papillary thyroid cancer |
publisher |
The Korean Association of Internal Medicine |
series |
The Korean Journal of Internal Medicine |
issn |
1226-3303 2005-6648 |
publishDate |
2020-09-01 |
description |
Background/Aims This study was conducted to identify prognostic factors in patients with papillary thyroid cancer (PTC) at the time of first radioactive iodine (RAI) therapy, and to evaluate the clinical value of the thyroglobulin (Tg) increase after RAI. Methods Serum Tg was sampled prior to (pre-Tg) and 7 days after RAI (post-Tg) in 680 patients with PTC. Patients were classified into excellent response (ER), biochemical incomplete response (BCIR), structural incomplete response (SIR), and indeterminate response (IR) groups using dynamic risk stratification at 6 to 18 months after RAI therapy. Results After RAI therapy, 514 patients (75.6%) had an ER, 34 (5.0%) had a BCIR, 13 (2.0%) had an SIR, and 119 (17.5%) had an IR. Pre-Tg level was significantly different among the groups, with the highest level being in the SIR group, followed by the BCIR, IR, and ER groups. However, post-Tg levels were not different among the groups. Post-Tg level increased significantly after RAI therapy compared to the pre-Tg level (mean 13.8 ± 32.2 ng/mL vs. 2.5 ± 8.9 ng/mL). In 422 patients whose pre-Tg level was < 1 ng/mL, 205 had post-Tg levels < 1 ng/mL, while 167 had post-Tg levels of 1 to 10 ng/mL, and 50 had levels > 10 ng/mL. No difference was observed in the response to therapy. Differences in RAI dose and uptake pattern were observed among the three groups. Conclusions Pre-Tg was useful as a prognostic factor in patients with PTC. In patients with low pre-Tg, increased post-Tg may reflect remnant tissue and does not help predict the prognosis. |
topic |
thyroid cancer, papillary radioactive iodine therapy thyroglobulin prognosis therapeutic response |
url |
http://www.kjim.org/upload/pdf/kjim-2018-173.pdf |
work_keys_str_mv |
AT heekyungkim theclinicalmeaningofpreandpostablationthyroglobulinlevelsatfirstradioiodinetherapyinpatientswithpapillarythyroidcancer AT jeeheeyoon theclinicalmeaningofpreandpostablationthyroglobulinlevelsatfirstradioiodinetherapyinpatientswithpapillarythyroidcancer AT jinseongcho theclinicalmeaningofpreandpostablationthyroglobulinlevelsatfirstradioiodinetherapyinpatientswithpapillarythyroidcancer AT seongyoungkwon theclinicalmeaningofpreandpostablationthyroglobulinlevelsatfirstradioiodinetherapyinpatientswithpapillarythyroidcancer AT suwoongyoo theclinicalmeaningofpreandpostablationthyroglobulinlevelsatfirstradioiodinetherapyinpatientswithpapillarythyroidcancer AT hocheolkang theclinicalmeaningofpreandpostablationthyroglobulinlevelsatfirstradioiodinetherapyinpatientswithpapillarythyroidcancer AT heekyungkim clinicalmeaningofpreandpostablationthyroglobulinlevelsatfirstradioiodinetherapyinpatientswithpapillarythyroidcancer AT jeeheeyoon clinicalmeaningofpreandpostablationthyroglobulinlevelsatfirstradioiodinetherapyinpatientswithpapillarythyroidcancer AT jinseongcho clinicalmeaningofpreandpostablationthyroglobulinlevelsatfirstradioiodinetherapyinpatientswithpapillarythyroidcancer AT seongyoungkwon clinicalmeaningofpreandpostablationthyroglobulinlevelsatfirstradioiodinetherapyinpatientswithpapillarythyroidcancer AT suwoongyoo clinicalmeaningofpreandpostablationthyroglobulinlevelsatfirstradioiodinetherapyinpatientswithpapillarythyroidcancer AT hocheolkang clinicalmeaningofpreandpostablationthyroglobulinlevelsatfirstradioiodinetherapyinpatientswithpapillarythyroidcancer |
_version_ |
1721212776064483328 |